Brain Cancer | Tumor

CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.

Finding Gratitude and Love for Cancer Patients and Caregivers

November 19th 2025, 10:00pm

Article

I reflect on my brain tumor journey, sharing how gratitude, love and connection with my parents and others strengthened me through difficult times.

Marine Corps Veteran and Marathoner Ran Through Brain Cancer Journey

November 17th 2025, 5:00pm

Article

For U.S. Marine Corps veteran and devout marathon runner Hank Donigan, not even a diagnosis of brain cancer could slow him down.

FDA Grants Drug Designation to Tinostamustine for Malignant Glioma

November 13th 2025, 5:00pm

Article

The FDA has granted orphan drug designation to tinostamustine, an investigational therapeutic, for the treatment of patients with malignant gliomas.

Sharing More Than 25 Years of Brain Tumor Survival

November 6th 2025, 6:00pm

Video

Jeannine Walston, who has contributed to CURE since 2015, was diagnosed with a brain tumor in March 1998.

Voranigo Continues to Benefit Patients With Grade 2 IDH-Mutated Glioma

November 4th 2025, 4:00pm

Article

Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay chemotherapy and radiation.

FDA Grants Exousia Pro Orphan Drug Designation in Glioma

October 29th 2025, 4:00pm

Article

Exousia Pro, Inc. received orphan drug designation from the FDA for malignant glioma, also known as glioblastoma multiforme or GBM.

FDA Grants Rare Pediatric Designation for Iopofosine-131 in Glioma Subset

October 27th 2025, 3:00pm

Article

The FDA granted rare pediatric disease designation to iopofosine-131 for treating relapsed or refractory pediatric high-grade glioma.

FDA Fast Tracks MT-125 for Glioblastoma

October 24th 2025, 1:29pm

Article

The FDA has granted fast track designation to MT-125 for the treatment of patients with glioblastoma.

GammaTile May Reduce Risk of Brain Tumor Recurrence or Death

October 21st 2025, 3:00pm

Article

In patients with operable, newly diagnosed brain metastases, GammaTile was associated with reduction in the risk of tumor recurrence or death.

Registration Open for the National Caregivers Self-Care and Tools Webinar Hosted by the End Brain Cancer Initiative

October 16th 2025, 9:58pm

Article

Registration is now open for the National Caregivers Self-Care and Tools online educational event on November 7th, 2025 at 11AM Pacific Time.